I-124 versus I-131 in the identification of suspected metastasis in patients well-differentiated thyroid cancer (WDTC)

被引：0
作者：
Van Nostrand, Douglas [1 ]
Moreau, S. [1 ]
Atkins, Frank [1 ]
Chennupati, S. [1 ]
Mete, Mihriye [4 ]
Burman, K. [2 ]
Wartofsky, L. [3 ]
机构：
[1] Wash Hosp Ctr, Div Nuc Med, Washington, DC USA
[2] Wash Hosp Ctr, Div Endo, Washington, DC USA
[3] Wash Hosp Ctr, Dept Med, Washington, DC USA
[4] Med Res Int, Washington, DC USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
340
引用
收藏
页数：2
相关论文
共 50 条
[21]   Diagnostic and post-therapy I-131 whole body scans in patients with well-differentiated thyroid carcinoma. [J].
Ozalp, E ;
Vural, G ;
Ercakmak, N ;
Aslan, S ;
Turgut, B .
JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) :235P-235P
[22]   Is I-131 whole-body imaging prior to radioidoine ablation in stages I and II well-differentiated thyroid cancer really necessary? [J].
Intenzo, CM ;
Kim, SM ;
Capuzzi, D .
RADIOLOGY, 2000, 217 :454-454
[23]   I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response [J].
Donika Plyku ;
Robert F. Hobbs ;
Di Wu ;
Carlos Garcia ;
George Sgouros ;
Douglas Van Nostrand .
Annals of Nuclear Medicine, 2022, 36 :213-223
[24]   The first experience with Bexarotene in patients with I-131 negative differentiated thyroid cancer [J].
Stokkel, M. P. M. ;
Smit, J. W. ;
Verkooijen, R. B. T. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 :S111-S111
[25]   I-131 uptake augmentation by thiazide diuretics in differentiated thyroid cancer patients [J].
Sayman, HB ;
Senmevsim, O ;
Kanmaz, B ;
Mete, C ;
Sager, S ;
Onsel, C ;
Sonmezoglu, K ;
Kabasakal, L ;
Uslu, I .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 :S466-S466
[26]   Low versus High I-131 Dose for Remnant Ablation in Differentiated Thyroid Cancer [J].
Hackshaw, Allan ;
Mallick, Ujjal .
CLINICAL MEDICINE & RESEARCH, 2009, 7 (1-2) :1-1
[27]   The Effects of I-131 Ablation/Metastasis Treatment on Hemorheological Parameters and Oxidative Stress in Patients with Differentiated Thyroid Cancer [J].
Sengoz, Tarik ;
Toprak, Emine Kilic ;
Yaylali, Olga ;
Oymak, Burak ;
Erkek, Ozgen Kilic ;
Ozdemir, Yasin ;
Yuksel, Dogangun ;
Kucukatay, Vural ;
Kucukatay, Melek Bor .
ACTA PHYSIOLOGICA, 2017, 221 :57-57
[28]   SIDE-EFFECTS OF RATIONAL DOSE I-131 THERAPY FOR METASTATIC WELL-DIFFERENTIATED THYROID-CARCINOMA [J].
VANNOSTRAND, D ;
NEUTZE, J ;
ATKINS, F .
JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (10) :1519-1527
[29]   I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer [J].
Kim, Choon-Young ;
Son, Seung Hyun ;
Jung, Ji-hoon ;
Kim, Do-Hoon ;
Jeong, Shin Young ;
Lee, Sang-Woo ;
Lee, Jaetae ;
Ahn, Byeong-Cheol .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[30]   Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131) [J].
Rault, Erwann ;
Vandenberghe, Stefaan ;
Van Holen, Roel ;
De Beenhouwer, Jan ;
Staelens, Steven ;
Lemahieu, Ignace .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) :423-430
12345